Business
IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Trends
POTOMAC, MD / ACCESS Newswire / November 25, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today ...
About this update from Igc Pharma, Inc.
[{"type":"text","content":"POTOMAC, MD / ACCESS Newswire / November 25, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced advances in MINT-AD, the Multimodal Interpretable Transformer for Alzheimer's. Leveraging data from the Health and Retirement Study (HRS) International Family of Studies, IGC Pharma aims to identify unknown socioeconomic risk factors and their interactions influencing aging and cognitive decline. This initiative is part of IGC Pharma's broader mission to revolutionize Alzheimer's treatment with precision medicine and AI-driven insights.","length":743,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"IGC Pharma, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1504,"height":890,"url":"https://media.zenfs.com/en/accesswire.ca/1382902c9ea83221d494fcbca53788e1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2eF6O7Wg5gMGsGaQPfEyQg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU2ODtjZj13ZWJw/https://media.zenfs.com/en/accesswire.ca/1382902c9ea83221d494fcbca53788e1","width":960,"height":568},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/zBTlqMgauT4s.CumsfhGPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNDIwO2NmPXdlYnA-/https://media.zenfs.com/en/accesswire.ca/1382902c9ea83221d494fcbca53788e1","width":1200,"height":710}},"href":"https://app.accessnewswire.com/imagelibrary/b3361829-9c94-444a-ba0e-2b1fe61128d8/igc-pharma-inc-2025.png","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Among the datasets used in MINT-AD training, IGC Pharma is leveraging 14 large-scale longitudinal aging and cognition studies spanning the USA, Africa, Mexico, China, Costa Rica, Puerto Rico, Chile, Brazil, England, Thailand, Indonesia, India, and Korea, all adhering to HRS protocol. This approach enables AI to identify critical socioeconomic factors contributing to early cognitive decline across populations with diverse sociocultural contexts, offering a new way to predict, stratify, and intervene before Alzheimer's takes hold.","length":538,"tagName":"p"},{"type":"text","content":""Understanding the socioeconomic factors that contribute to cognitive decline is critica...